> Visiting Washington/Alaska Chapter | Local links | End Visit > visit Canadian site

 

Live Help

View All Chapters

HOME
PATIENT SERVICES
DISEASE INFORMATION
HOW TO HELP
ADVOCACY
SCIENCE/PROFESSIONALS
LLS
About Us
Contact Us
Free eNews
Careers
Calendar
Press Room
News
About Us
Board & Staff Bios
eNewsletter Archives
Awards
SCOR Recipients
Our History
Email:
Password:
Remember Me
Not Yet Registered?



This website is certified by Health On the Net Foundation. Click to verify.
LLS
LLS > Press Room > News  print page
email this page
 $  Donate

 		 Survival for High Risk Childhood Leukemia More Than Doubled by New Treatment
October 7, 2009 (Research Reports) - Results of a phase two clinical trial published October 5th in the Journal of Clinical Oncology show that adding continuous daily doses of a targeted drug called imatinib mesylate to regular chemotherapy more than doubled three-year survival rates for children with a high risk type of blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Read more.



back to top
The Leukemia & Lymphoma SocietyŽ (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.
Need Help? Contact us by email, mail, or call (800) 955-4572 copyright | disclaimer | link | privacy | security
spanish french portuguese